BIOGRAPHY

Josh has worked with start-ups, middle-market companies, Fortune 100 healthcare organizations, major US and EU health systems, and global healthcare companies. His clients have included Johnson & Johnson, Medtronic, Ethicon Endo-Surgery, Pfizer, Abbott, Alcon, Sanofi, Pharmacia AB, Karl Storz, CooperVision, Accuray, and C.R. Bard. He has engaged with many of the largest, most sophisticated hospital systems in the United States, including Sutter Health, Advocate Health Care, UNC Health, Catholic Health System, McLaren Health Care, Barnes-Jewish, and many others.

Josh's key differentiator is his ability to evaluate healthcare from both the clinical and business / operational perspectives. He understands how physicians, surgeons, value analysis teams, supply chain, and ORs actually work, and can help his clients understand the financial, management, and strategic priorities of CEOs, CFOs, COOs, and CMOs. The result is achieving adoption of new technologies and products. As an applied health economist, he helps translate clinical evidence and product capabilities into compelling economic value propositions addressing cost-effectiveness, clinical workflow optimization, and return on investment. 

In addition to his US market experience, Josh has advised organizations across multiple international markets with emphasis on Europe and Germany. His international perspective allows him to support companies who desire to enter the US market, and reciprocally assist US firms enter XUS environments.

Josh Feldstein founded CAVA Robotics in 2011 and serves as its President. He has authored two books, a dozen peer-reviewed publications and textbook chapters, and serves as Health Economics Editor for American Health and Drug Benefits. He holds a B.A. in Pre-Law English, cum laude, from Queens College, City University of New York, has completed graduate studies in business, and speaks C-1 level German.